# TNTCRT (NCT03177382)

> Total Neoadjuvant Treatment vs. Chemoradiotherapy in Local Advanced Rectal Cancer With High Risk Factors

No report yet. It can be ordered.

- Drugs tested: none (the trial tests no drug)
- Indication: high-risk locally advanced rectal cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03177382
- Phase: PHASE3
- Status: UNKNOWN
- Sponsor: West China Hospital
- Conditions: Total Neoadjuvant Treatment; Chemoradiotherapy; Local Advanced Rectal Cancer; High Risk Factors
- Interventions: Total neoadjuvant treatment; concurrent chemoradiotherapy; TME; Adjuvant chemotherapy
- Enrollment: 458
- Primary outcome: disease free survival

## Indexed commentary on TNTCRT so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 7
- Podcasts: 1

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=tntcrt-nct03177382

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03177382", "email": "<work email>"}; the inbox owner confirms by the emailed link.